For the quarter ended December 2025, Ingram Micro (INGM) reported revenue of $14.88 billion, up 11.5% over the same period last year. EPS came in at $0.96, compared to $0.92 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $14.13 billion, representing a surprise of +5.33%. The company delivered an EPS surprise of +6.67%, with the consensus EPS estimate being $0.90.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and h ...

All right, no hundreds of dollar oil today, no closing of the Straits of Hormuz. Anyway, joining us, uh, Dan Briette is a former energy secretary and my good friends Art Laugher, former Reagan economist, Steve Moore, host of More Money on WABC radio. Gentlemen, thank you.Dan Briette, fake news right just almost at the start of this show, uh, Reuters uh, listening to the IRGC, if you can believe that, that the Straits of Hormuz are being closed by Iran. Our Jennifer Griffith who's a national security corresp ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased ordinary shares of uniQure N.V. during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought uniQure shares between September 24, 2025, and October 31, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by April 13, 2026 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Case Allegations - The lawsuit alleges that uniQure misrepresented and/or failed to disclose critical information regarding the design of its Pivotal Study for a drug candidate targeting Huntington's Disease, including the lack of full FDA approval [5]. - It is claimed that uniQure downplayed the likelihood of needing to delay its Biologics License Application (BLA) timeline due to the necessity of additional studies [5]. - The lawsuit asserts that the defendants' statements regarding uniQure's business and prospects lacked a reasonable basis, leading to investor damages when the true information became public [5].

Core Viewpoint - CAPREIT is acquiring all outstanding units of ERES for $1.19 per unit in an all-cash transaction, valuing ERES at approximately $441 million, including debt [2][4]. Transaction Details - The transaction is a culmination of ERES's strategic review process overseen by a Special Committee of independent trustees [3]. - ERES has returned €1.90 per unit (approximately $2.96) in special distributions since 2024, leading to a total return of approximately $4.15 per unit, which is about 32% above the closing price of $3.15 on November 6, 2024 [4][8]. - The Board of ERES has unanimously recommended the transaction as being in the best interests of ERES and its unitholders [5][7]. Strategic Review and Recommendations - The transaction is seen as a successful completion of ERES's value-enhancement strategy, providing immediate liquidity and certainty of value to unitholders [8]. - The Special Committee conducted a thorough strategic review, evaluating various proposals and determining that the transaction optimizes value for unitholders [6][8]. - Fairness opinions from BMO Capital Markets and Haywood support the transaction's consideration of $1.19 per unit [7][14]. Approval Process - The transaction requires approval from two-thirds of the votes cast by ERES unitholders and a simple majority from minority unitholders, excluding CAPREIT [9][10]. - A special meeting for unitholders is expected to be held in April 2026, with the transaction anticipated to close in the second quarter of 2026 [10]. Financial Advisors and Valuation - BMO Capital Markets and Haywood provided fairness opinions and a formal valuation, indicating the fair market value of ERES units is between $1.05 and $1.25 per unit [14]. - The transaction is structured to have limited closing conditions and does not require regulatory approvals [8][9]. Future Implications - Upon completion, ERES units will be delisted from the Toronto Stock Exchange, and ERES will cease to be a reporting issuer in Canada [12]. - The transaction allows CAPREIT to manage the remaining assets in alignment with its long-term objectives while providing a cash exit for ERES unitholders [6].

[ENPH]• Vol: 6,112,709+$2.44+5.77%$44.71[Axon Enterprise][AXON]• Vol: 1,314,943+$29.62+5.46%$572.02## Top Losing Stocks[AES][AES]• Vol: 80,251,545-$3.0717.77%$14.21[Norwegian Cruise Line][NCLH]• Vol: 46,543,494-$2.6110.53%$22.18[Estee Lauder Companies][EL]• Vol: 5,241,965-$9.288.48%$100.19[Elevance Health][ELV]• Vol: 4,481,568-$25.938.10%$294.07[TE Connectivity][TEL]• Vol: 5,037,713-$18.177.89%$211.98 Oil Explorers Are About to Get Absolutely Whipsawed and XOP Captures Every Single Move - 24/7 Wall St. [S&P ...

Group 1 - The presentation is led by Matthew Cost from Morgan Stanley's Research Division, focusing on important research disclosures [1] - Mark Douglas, CEO of MNTN, is present for the discussion, indicating a focus on the internet sector [2]

Core Viewpoint - An investigation has been initiated regarding the fairness of the acquisition of European Wax Center, Inc. by General Atlantic, targeting all individuals or entities that purchased EWCZ stock prior to February 10, 2026 [1] Group 1 - The investigation is being conducted by Levi & Korsinsky, LLP [1] - The focus of the investigation is on the acquisition process and its fairness [1]

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Stockholders of an Investigation into the Fairness of the Acquisition of Kennedy-Wilson Holdings, Inc. by Fairfax Financial Holdings Limited [Accessibility Statement] Skip NavigationNEW YORK, March 2, 2026 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who purchased Kennedy-Wilson Holdings, Inc. ("Kennedy-Wilson" or the "Company") (NYSE: KW) stock prior to February 17, 2026.You are hereby notified ...

Core Viewpoint - Levi & Korsinsky, LLP has initiated an investigation into the fairness of the acquisition of Clearwater Analytics Holdings, Inc. by a consortium led by Permira and Warburg Pincus, focusing on whether the merger price of $24.55 per share adequately reflects the company's value and if all material facts were disclosed to shareholders [1]. Summary by Relevant Sections Acquisition Details - Clearwater stockholders are expected to receive $24.55 per share in cash as a result of the acquisition [1]. Investigation Focus - The investigation aims to determine if the Board of Clearwater has harmed stockholders by failing to maximize the merger price and whether all material facts were properly disclosed to stockholders [1]. Legal Representation - Levi & Korsinsky is a nationally recognized law firm with expertise in prosecuting securities litigation and has recovered hundreds of millions of dollars for aggrieved shareholders [1].

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Stockholders of an Investigation into the Fairness of the Acquisition of Mister Car Wash, Inc. by Leonard Green & Partners, L.P. [Accessibility Statement] Skip NavigationNEW YORK, March 2, 2026 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who purchased Mister Car Wash, Inc. ("Mister Car Wash" or the "Company") (NASDAQ: MCW) stock prior to February 18, 2026.You are hereby notified that Levi & Kor ...